Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gene Therapy
Researchers from Jichi Medical University, Department of Medicine detail findings in gene therapy
April 29th, 2008
A new study, 'Cell and gene therapy using mesenchymal stem cells (MSCs),' is now available. According to a study from Tochigi, Japan, "Mesenchymal stem cells (MSCs) are considered to be a promising platform for cell and gene therapy for a variety of diseases. First, in the field of hematopoietic stem cell transplantation, there are two applications of MSCs: 1) the improvement of stem cell engrafting and the acceleration of hematopoietic reconstitution based on the hematopoiesis-supporting ability; and 2) the treatment of severe graft-versus-host disease (GVHD) based on the immunomodulatory ability." "Regarding the immunosuppressive ability, we found that nitric oxide...
Source: Cancer Weekly (2008-04-29)
|
